Donna Hildebrand Kralowetz net worth and biography

Donna Kralowetz Biography and Net Worth

Donna Hildebrand Kralowetz is the Sr. VP of Fin. & Principal Accounting Officer at Syneos Health Inc.

What is Donna Hildebrand Kralowetz's net worth?

The estimated net worth of Donna Hildebrand Kralowetz is at least $323,373.60 as of July 8th, 2022. Ms. Kralowetz owns 6,805 shares of Syneos Health stock worth more than $323,374 as of September 29th. This net worth approximation does not reflect any other assets that Ms. Kralowetz may own. Learn More about Donna Hildebrand Kralowetz's net worth.

How old is Donna Hildebrand Kralowetz?

Ms. Kralowetz is currently 51 years old. There are 6 older executives and no younger executives at Syneos Health. The oldest executive at Syneos Health is Ms. Michelle Keefe, CEO & Director, who is 55 years old. Learn More on Donna Hildebrand Kralowetz's age.

How do I contact Donna Hildebrand Kralowetz?

The corporate mailing address for Ms. Kralowetz and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected] Learn More on Donna Hildebrand Kralowetz's contact information.

Has Donna Hildebrand Kralowetz been buying or selling shares of Syneos Health?

In the last ninety days, Donna Hildebrand Kralowetz has sold $84,060.84 in Syneos Health stock. Most recently, Donna Hildebrand Kralowetz sold 1,149 shares of the business's stock in a transaction on Friday, July 8th. The shares were sold at an average price of $73.16, for a transaction totalling $84,060.84. Following the completion of the sale, the chief accounting officer now directly owns 6,805 shares of the company's stock, valued at $497,853.80. Learn More on Donna Hildebrand Kralowetz's trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 12 times. They sold a total of 29,562 shares worth more than $2,341,080.56. The most recent insider tranaction occured on July, 28th when COO Michael Lee Brooks sold 1,002 shares worth more than $78,156.00. Insiders at Syneos Health own 0.3 % of the company. Learn More about insider trades at Syneos Health.

Information on this page was last updated on 7/28/2022.

Donna Hildebrand Kralowetz Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/8/2022Sell1,149$73.16$84,060.846,805View SEC Filing Icon  
1/31/2022Sell1,055$90.00$94,950.00View SEC Filing Icon  
9/3/2021Sell248$94.30$23,386.40View SEC Filing Icon  
6/18/2021Sell590$85.03$50,167.707,057View SEC Filing Icon  
See Full Table

Donna Hildebrand Kralowetz Buying and Selling Activity at Syneos Health

This chart shows Donna Hildebrand Kralowetz's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $47.52
Low: $46.38
High: $47.72

50 Day Range

MA: $63.12
Low: $46.50
High: $79.14

2 Week Range

Now: $47.52
Low: $46.24
High: $104.18

Volume

17,000 shs

Average Volume

925,675 shs

Market Capitalization

$4.88 billion

P/E Ratio

17.86

Dividend Yield

N/A

Beta

1.74